{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T09:10:08Z","timestamp":1772356208140,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Vice-chancellor for Research and Technology, Hamadan University of Medical Sciences","award":["9607254682"],"award-info":[{"award-number":["9607254682"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","injuryjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Injury"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.injury.2018.07.006","type":"journal-article","created":{"date-parts":[[2018,7,6]],"date-time":"2018-07-06T10:49:20Z","timestamp":1530874160000},"page":"1746-1749","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Does zoledronate therapy make mandibular bone susceptible to fracture? A radiographical and biomechanical study in rats"],"prefix":"10.1016","volume":"49","author":[{"given":"Mohammad","family":"Zandi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbas","family":"Shokri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Mousavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanaz","family":"Rajaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naser","family":"Mohammad Gholi Mezerji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.injury.2018.07.006_bib0005","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.oooo.2015.02.005","article-title":"Mandibular inferior cortical bone thickness on panoramic radiographs in patients using bisphosphonates","volume":"119","author":"Torres","year":"2015","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.injury.2018.07.006_bib0010","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.bone.2015.06.003","article-title":"Bone cross-sectional geometry is not associated with atypical femoral fractures in Asian female chronic bisphosphonate users","volume":"79","author":"Chou","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.injury.2018.07.006_bib0015","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.bone.2010.08.008","article-title":"Novel actions of bisphosphonates in bone: preservation of osteoblast and osteocyte viability","volume":"49","author":"Bellido","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.injury.2018.07.006_bib0020","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.bone.2013.07.012","article-title":"Atypical fracture of the tibial diaphysis associated with bisphosphonate therapy: a case report","volume":"56","author":"Bissonnette","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.injury.2018.07.006_bib0025","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jc.2004-0952","article-title":"Severely suppressed bone turnover: a potential complication of alendronate therapy","volume":"90","author":"Odvina","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.injury.2018.07.006_bib0030","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.bone.2012.05.010","article-title":"Atypical femur fractures among breast cancer and multiple myeloma patients receiving intravenous bisphosphonate therapy","volume":"51","author":"Chang","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.injury.2018.07.006_bib0035","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1001\/jama.2011.190","article-title":"Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women","volume":"305","author":"Park-Wyllie","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.injury.2018.07.006_bib0040","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.bone.2014.01.011","article-title":"Absence of femoral cortical thickening in long-term bisphosphonate users: implications for atypical femur fractures","volume":"62","author":"Chen","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.injury.2018.07.006_bib0045","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1302\/0301-620X.89B3.18146","article-title":"Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution","volume":"89","author":"Goh","year":"2007","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.injury.2018.07.006_bib0050","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/BOT.0b013e318172841c","article-title":"Low-energy femoral shaft fractures associated with alendronate use","volume":"22","author":"Neviaser","year":"2008","journal-title":"J Orthop Trauma"},{"key":"10.1016\/j.injury.2018.07.006_bib0055","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2265.2009.03581.x","article-title":"Unusual mid-shaft fractures during long-term bisphosphonate therapy","volume":"72","author":"Odvina","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.injury.2018.07.006_bib0060","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/jbmr.253","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American society for bone and mineral research","volume":"25","author":"Shane","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.injury.2018.07.006_bib0065","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/jbmr.1893","article-title":"Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: a systematic review and meta-analysis","volume":"28","author":"Gedmintas","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.injury.2018.07.006_bib0070","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/RHU.0b013e3181cf3e3d","article-title":"Atypical insufficiency fracture of the tibia associated with long-term bisphosphonate therapy","volume":"16","author":"Breglia","year":"2010","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.injury.2018.07.006_bib0075","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1752-1947-6-50","article-title":"Bilateral atypical insufficiency fractures of the proximal tibia and a unilateral distal femoral fracture associated with long-term intravenous bisphosphonate therapy: a case report","volume":"6","author":"Imbuldeniya","year":"2012","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.injury.2018.07.006_bib0080","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/dvdy.20134","article-title":"Conserved molecular program regulating cranial and appendicular skeletogenesis","volume":"231","author":"Eames","year":"2004","journal-title":"Dev Dyn"},{"key":"10.1016\/j.injury.2018.07.006_bib0085","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1469-7580.2005.00473.x","article-title":"Relations and interactions between cranial mesoderm and neural crest populations","volume":"207","author":"Noden","year":"2005","journal-title":"J Anat"},{"key":"10.1016\/j.injury.2018.07.006_bib0090","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.bone.2014.04.012","article-title":"A large amount of microdamages in the cortical bone around fracture site in a patient of atypical femoral fracture after long-term bisphosphonate therapy","volume":"64","author":"Iwata","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.injury.2018.07.006_bib0095","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bone.2009.09.003","article-title":"Non-enzymatic glycation alters microdamage formation in human cancellous bone","volume":"46","author":"Tang","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.injury.2018.07.006_bib0100","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S8756-3282(00)00434-8","article-title":"Influence of nonenzymatic glycation on biomechanical properties of cortical bone","volume":"28","author":"Vashishth","year":"2001","journal-title":"Bone"},{"issue":"695","key":"10.1016\/j.injury.2018.07.006_bib0105","article-title":"Mandibular cortical bone evaluation on cone beam computed tomography images of patients with bisphosphonate associated osteonecrosis of the jaws","volume":"113","author":"Torres","year":"2012","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.injury.2018.07.006_bib0110","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1359\/jbmr.070906","article-title":"Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure","volume":"23","author":"Recker","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.injury.2018.07.006_bib0115","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2265.2009.03581.x","article-title":"Unusual mid-shaft fractures during long-term bisphosphonate therapy","volume":"72","author":"Odvina","year":"2010","journal-title":"Clin Endocrinol Oxf"},{"key":"10.1016\/j.injury.2018.07.006_bib0120","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1210\/jc.2005-0057","article-title":"Long-term safety of bisphosphonates","volume":"90","author":"Ott","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.injury.2018.07.006_bib0125","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.bone.2010.12.033","article-title":"Atypical fractures and bisphosphonate therapy: a cohort study of patients with femoral fracture with radiographic adjudication of fracture site and features","volume":"48","author":"Giusti","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.injury.2018.07.006_bib0130","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1138\/20060248","article-title":"Mineralization, microdamage, and matrix: how bisphosphonates influence material properties of bone","volume":"4","author":"Allen","year":"2007","journal-title":"BoneKEy-Osteovision"},{"key":"10.1016\/j.injury.2018.07.006_bib0135","doi-asserted-by":"crossref","first-page":"117","DOI":"10.11005\/jbm.2014.21.2.117","article-title":"Can dental cone beam computed tomography assess bone mineral density?","volume":"21","author":"Kim","year":"2014","journal-title":"J Bone Metab"},{"issue":"1196","key":"10.1016\/j.injury.2018.07.006_bib0140","article-title":"Beyond a reasonable doubt? Bisphosphonates and atypical femur fractures","volume":"50","author":"Abrahamsen","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.injury.2018.07.006_bib0145","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jcms.2016.10.015","article-title":"The starting point for bisphosphonate-related osteonecrosis of the jaw: alveolar bone or oral mucosa? A randomized, controlled experimental study","volume":"45","author":"Zandi","year":"2017","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.injury.2018.07.006_bib0150","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1016\/j.injury.2017.10.026","article-title":"Evaluation of mandibular fracture healing in rats under zoledronate therapy: a histologic study","volume":"48","author":"Zandi","year":"2017","journal-title":"Injury"},{"key":"10.1016\/j.injury.2018.07.006_bib0155","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.2106\/JBJS.J.01199","article-title":"Atypical subtrochanteric femoral fractures in patients with skeletal malignant involvement treated with intravenous bisphosphonates","volume":"93","author":"Puhaindran","year":"2011","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.injury.2018.07.006_bib0160","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bone.2011.02.003","article-title":"Bisphosphonates in oncology","volume":"49","author":"Coleman","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.injury.2018.07.006_bib0165","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bone.2010.10.159","article-title":"Bisphosphonate effects on bone turnover, microdamage, and mechanical properties: what we think we know and what we know that we don\u2019t know","volume":"49","author":"Allen","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.injury.2018.07.006_bib0170","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.jcms.2015.08.008","article-title":"Perioperative discontinuation of intravenous bisphosphonate therapy reduces the incidence and severity of bisphosphonate-related osteonecrosis of the jaw: a randomized, controlled, prospective experimental study in rats","volume":"43","author":"Zandi","year":"2015","journal-title":"J Craniomaxillofac Surg"}],"container-title":["Injury"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0020138318303620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0020138318303620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T11:58:54Z","timestamp":1558180734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0020138318303620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0020138318303620"],"URL":"https:\/\/doi.org\/10.1016\/j.injury.2018.07.006","relation":{},"ISSN":["0020-1383"],"issn-type":[{"value":"0020-1383","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does zoledronate therapy make mandibular bone susceptible to fracture? A radiographical and biomechanical study in rats","name":"articletitle","label":"Article Title"},{"value":"Injury","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.injury.2018.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}